Daily Ards Research Analysis
A bench-top ARDS study shows that suction catheter size relative to endotracheal tube diameter critically determines PEEP stability during closed suction, challenging 2022 AARC guidance. A comprehensive review integrates the immunopathogenesis and biomarkers of COVID-19 cytokine storm with therapeutic strategies. A neonatal case series underscores rare anatomic nasal lesions as causes of life-threatening respiratory distress requiring prompt diagnosis.
Summary
A bench-top ARDS study shows that suction catheter size relative to endotracheal tube diameter critically determines PEEP stability during closed suction, challenging 2022 AARC guidance. A comprehensive review integrates the immunopathogenesis and biomarkers of COVID-19 cytokine storm with therapeutic strategies. A neonatal case series underscores rare anatomic nasal lesions as causes of life-threatening respiratory distress requiring prompt diagnosis.
Research Themes
- Ventilator management and airway suction in ARDS
- Cytokine storm immunopathogenesis and targeted therapy in COVID-19
- Congenital nasal airway obstruction and neonatal respiratory compromise
Selected Articles
1. Impact of catheter size and endotracheal tube diameter on PEEP stability during closed suctioning in a simulated ARDS patient: a bench top study.
Using a lung simulator modeling severe ARDS, the study showed that larger suction catheters and smaller ETT diameters caused greater PEEP and tidal volume losses during closed suctioning. Adhering to 2022 AARC recommendations resulted in significant PEEP reductions, whereas limiting catheter size to ≤50% of ETT inner diameter (1993 guidance) preserved PEEP better.
Impact: It directly informs a common ICU procedure in ARDS and challenges recent guidance with actionable, physiologically grounded evidence.
Clinical Implications: For adult ARDS, select suction catheters no larger than 50% of the ETT inner diameter, prefer larger ETTs when feasible to reduce PEEP loss, and monitor PEEP/Vt during suctioning. Be cautious that following 2022 AARC recommendations may induce clinically relevant PEEP drops.
Key Findings
- Closed suction with larger catheters and smaller ETTs produced greater PEEP and tidal volume loss in a severe ARDS simulator.
- Catheter diameter independently influenced both PEEP and tidal volume loss; ETT diameter and tidal volume strongly influenced PEEP loss.
- Limiting catheter size to ≤50% of ETT inner diameter preserved PEEP better (aligning with 1993 AARC guidance) than 2022 recommendations.
Methodological Strengths
- Controlled bench simulation allowing isolation of catheter and ETT size effects across standardized ventilator settings
- Clinically relevant endpoints (PEEP and tidal volume loss) directly tied to lung-protective ventilation
Limitations
- Bench-top simulation without patient-level validation; generalizability to diverse lung mechanics and secretion loads is uncertain
- Incomplete reporting of full ventilator parameter matrix; no assessment of gas exchange or hemodynamic consequences
Future Directions: Prospective clinical studies to validate catheter-to-ETT sizing thresholds in ARDS; evaluate effects across ventilator platforms, secretion loads, humidification, and in high-PEEP strategies.
OBJECTIVES: Endotracheal suctioning is performed in mechanically ventilated patients to remove airway secretions. The American Association for Respiratory Care (AARC) has provided recommendations on endotracheal suctioning techniques and catheter size selection over the years (1993, 2010, 2022). This bench-top study aimed to compare the effects of closed-suction system manoeuvres performed with different catheter diameters on PEEP and Tidal Volume in an experimental setup of mechanical ventilation in a simulated ARDS scenario. METHODS: A lung simulator was used to simulate severe ARDS in adult patients. Endotracheal suctioning was performed using a closed suction system with two catheter sizes (12 and 14 Fr). and two endotracheal tube diameters (7 mm and 8 mm). The lung simulator was ventilated with different combinations of PEEP (10,15 cmH RESULTS: The median PEEP loss was -1.54 cmH CONCLUSIONS: Endotracheal tube diameter and tidal volume significantly influenced PEEP loss, and suction catheter diameter significantly influenced both PEEP and tidal volume loss during closed suctioning in simulated adults with ARDS. IMPLICATIONS FOR CLINICAL PRACTICE: Results of this bench-top study suggest that, for adult patients with ARDS, the suction catheter should not exceed 50% of the inner diameter of the endotracheal tube, as recommended in the 1993 AARC guidelines. In this bench-top study, following the 2022 AARC recommendations led to a significant reduction in PEEP levels during endotracheal suctioning.
2. Delving deeper in the eye of the hurricane: Immunopathogenesis & molecular characterization of cytokine storm in COVID-19, association with disease severity & the therapeutic regimens.
This narrative review synthesizes mechanisms driving the COVID-19 cytokine storm, mapping viral entry and immune signaling to clinical severity, biomarkers, and organ injury including ARDS. It contrasts COVID-19 with other cytokine storm conditions and appraises immunoregulatory therapies to mitigate hyperinflammation.
Impact: By integrating molecular pathways with clinical biomarkers and therapies, it guides hypothesis generation and rational use of immunomodulators in severe COVID-19.
Clinical Implications: Supports biomarker-informed care (e.g., IL-6, CRP, ferritin, D-dimer) and timing/selection of immunomodulators (corticosteroids, IL-6/JAK inhibitors), while highlighting heterogeneity that necessitates patient stratification.
Key Findings
- Excess proinflammatory cytokine/chemokine release underlies innate immune dysregulation and ARDS/multiorgan failure in severe COVID-19.
- Comparative analysis with other cytokine storm syndromes clarifies shared and distinct pathways in COVID-19.
- Genetic and physiological host factors correlate with disease exacerbation; immunoregulatory therapies are tailored to curb hyperinflammation.
Methodological Strengths
- Comprehensive synthesis linking molecular mechanisms to clinical biomarkers and therapies
- Cross-disease comparisons providing contextual insights into cytokine storm biology
Limitations
- Narrative review without PRISMA-guided systematic methods; potential selection bias
- No quantitative meta-analysis to estimate effect sizes or heterogeneity
Future Directions: Prospective, biomarker-stratified trials testing timing and combinations of immunomodulators; multi-omics profiling to refine endotypes of hyperinflammation.
The COVID-19 pandemic elicited by SARS-CoV-2 has led to a world-wide crisis, affecting a substantial percentage of the entire global population, and has engendered profound morbidity and fatalities. SARS-CoV-2 mediates its entry into human respiratory epithelial cells via interaction between viral Spike protein (S) and ACE2 receptor and enacts the host cell tropism by numerous molecular factors and inflammatory signaling pathways. The complex molecular immunopathogenesis involves loss of regulatory control of the generation & release of proinflammatory cytokines at both local as well as systemic levels. Excessive secretion of pro-inflammatory cytokines and chemokines leads to the dysregulation of the innate immune system leading to the cytokine storm. Owing to the enormous release of inflammatory factors and active mediators, cytokine storm induces severe damage to secondary tissues, leading to Acute Respiratory Distress Syndrome (ARDS) or multiple-organ failure, which evokes aggravation of the disease and eventually death. Comparisons amid COVID-19 cytokine storm and several other types of cytokine storm associated diseases, gives proper insights about the etiology of cytokine storm in COVID-19. Various genetic and physiological factors contribute to severe disease progression and aggravation of the disease. In that view, several immunoregulatory therapies have been tailored to curb the cytokine storm, which might be crucial in improving the success rates of various treatment strategies as well as in lowering the mortality rate in COVID-19 patients. This review elucidates the hallmarks of COVID-19 cytokine storm, immunopathogenesis, disease progression, biomarkers, and therapeutic interventions.
3. Newborn nasal obstruction: Rare anatomical causes to consider.
This retrospective case series of four neonates with respiratory distress details rare congenital nasal malformations—bilateral choanal atresia (with CHARGE), CNPAS with solitary median mega-incisor, isolated CNPAS with midnasal hypoplasia, and bilateral congenital dacryocystoceles. Early endoscopic and imaging-based diagnosis enabled tailored medical or surgical management.
Impact: It raises awareness of rare but treatable anatomic causes of neonatal respiratory compromise, informing timely diagnostic workups.
Clinical Implications: In neonates with respiratory distress and feeding difficulty, promptly consider congenital nasal anomalies; perform nasal endoscopy and craniofacial imaging, involve multidisciplinary teams, and tailor medical vs surgical interventions based on severity.
Key Findings
- Four neonates with respiratory distress had rare congenital nasal anomalies confirmed by endoscopy and craniofacial imaging.
- Conditions included bilateral choanal atresia (CHARGE syndrome), CNPAS with solitary median mega-incisor, isolated CNPAS with midnasal hypoplasia, and bilateral congenital dacryocystoceles.
- Management ranged from medical to surgical depending on obstruction severity; early diagnosis is essential to avoid complications.
Methodological Strengths
- Endoscopic and imaging confirmation of diagnoses
- Detailed clinical phenotyping and management descriptions
Limitations
- Very small sample (n=4) and single-center retrospective design
- No standardized diagnostic protocol or long-term outcomes reported
Future Directions: Develop multicenter registries and standardized diagnostic algorithms; assess long-term respiratory and developmental outcomes after intervention.
Neonatal nasal obstruction, though rare, can be life-threatening due to the obligate nasal breathing pattern in newborns. Even partial obstruction may compromise ventilation and feeding. This study aims to describe rare anatomical causes of neonatal nasal obstruction, highlighting their clinical presentation, diagnostic evaluation, and management. A retrospective review was conducted of four neonates with respiratory distress who were diagnosed with congenital nasal malformations through endoscopic examination and craniofacial imaging. The identified cases included bilateral choanal atresia in a patient with CHARGE syndrome, congenital nasal pyriform aperture stenosis (CNPAS) with a solitary median mega-incisor, isolated CNPAS with midnasal hypoplasia, and bilateral congenital dacryocystoceles. Symptoms ranged from noisy breathing to feeding intolerance. Management included both medical and surgical interventions depending on the severity of the obstruction. Although infrequent, anatomical nasal anomalies should be promptly considered in neonates presenting with respiratory distress, as early diagnosis and appropriate treatment are essential to avoid complications and ensure favourable outcomes.